M EN2 (Eprosartan mesylate 400 mg)

Pill imprint M EN2 has been identified as Eprosartan mesylate 400 mg.

Eprosartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors. There is positive evidence of human fetal risk during pregnancy. Eprosartan 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M EN2

Eprosartan mesylate 400 mg M EN2
Eprosartan mesylate
Imprint:
M EN2
Strength:
400 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Angiotensin II inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Matrix Laboratories Limited

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)